Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_00837
Species: Homo sapiens
Position : chr8:128264000-128277000
Year: 2024
Title: Selective Enhancer Gain-of-Function Deregulates MYC Expression in Multiple Myeloma.
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: plasma cell myeloma
PMID:  39312195
MONDO: MONDO:0009693
Tissue: blood
Tissue Ontology ID: UBERON:0000178
Cell Source: ANBL-6
CVCL ID: CVCL_5425
Cell Type: plasma cell
Cell Ontology ID: CL:0000786
Experiment Type: Enhancer activity assay; TF binding assay; Functional perturbation assay; Chromatin interaction assay
High Throughput Method: Pooled CRISPRi tiling screen; H3K27ac ChIP-seq; MAF ChIP-seq; Micro-C
Low Throughput Method: Individual CRISPRi; CRISPR-Cas9 MAF-binding-site mutagenesis; Dual-luciferase reporter assay; qRT-PCR
About Target Gene
Target gene : MYC
About TF
TF name : MAF
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
MAF AP-1 transcription factor network pid 71
MAF C-MYB transcription factor network pid 87
MAF Calcineurin-regulated NFAT-dependent transcription in lymphocytes pid 50
MAF Kaposi sarcoma-associated herpesvirus mirtarbase 13
MAF Hs_TYROBP_Causal_Network_WP3945_90843 wikipathways 54
Enhancer Associated Network
Overlapping Enhancers (hg38) 2 found
Enhancer ID Position Tissue Cell Disease
E_03876 chr8:126650000-129950000 colon malignant cell NA
E_00836 chr8:128264000-128277000 blood plasma cell plasma cell myeloma
Expression of Target Genes for the Enhancer